| Literature DB >> 22017961 |
Konstantina Dimitrakopoulou1, Charalampos Tsimpouris, George Papadopoulos, Claudia Pommerenke, Esther Wilk, Kyriakos N Sgarbas, Klaus Schughart, Anastasios Bezerianos.
Abstract
BACKGROUND: The immune response to viral infection is a temporal process, represented by a dynamic and complex network of gene and protein interactions. Here, we present a reverse engineering strategy aimed at capturing the temporal evolution of the underlying Gene Regulatory Networks (GRN). The proposed approach will be an enabling step towards comprehending the dynamic behavior of gene regulation circuitry and mapping the network structure transitions in response to pathogen stimuli.Entities:
Year: 2011 PMID: 22017961 PMCID: PMC3219564 DOI: 10.1186/2043-9113-1-27
Source DB: PubMed Journal: J Clin Bioinforma ISSN: 2043-9113
GO enrichment analysis
| GO Biological Process Term | Percentage (%) | P-Value |
|---|---|---|
| GO:0002376:immune system process | 7.5 | 7.45E-31 |
| GO:0050896:response to stimulus | 15.2 | 1.83E-11 |
| GO:0009987:cellular process | 48 | 1.22E-06 |
| GO:0051704:multi-organism process | 2.7 | 1.54E-06 |
| GO:0016265:death | 3.2 | 0.001708142 |
| GO:0040011:locomotion | 2.3 | 0.005231518 |
| GO:0008152:metabolic process | 35.4 | 0.036706589 |
| GO:0016043:cellular component organization | 10 | 0.037186976 |
| GO:0032502:developmental process | 14.2 | 0.061325344 |
Biological Process GO enrichment analysis of the 3500 genes included in our dataset. The analysis was implemented with DAVID Bioinformatics Resources functional annotation tool. 1429 out of the 3500 genes are not yet characterized with regard to biological process GO terms.
Figure 1Dunn Index results. Boxplot with Dunn Index results for k-means clustering. The x-axis represents the cluster number, while the y-axis represents the Dunn's cluster validity index scores. The experiment was repeated 100 times and the maximal Dunn Index score values were observed in the range of 19-36 cluster size.
Top Scorer Clusters
| Time Point (day p.i.) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 | 18 | 24 | 15 | 0 | 17 | 18 | 15 | 24 | 25 | 17 | 25 | 15 | 18 | 24 | 17 | 25 | 15 | 24 | 18 | 25 | 24 | 15 | 17 | 18 | |
| 17 | 18 | 24 | 15 | 20 | 17 | 24 | 15 | 18 | 25 | 17 | 25 | 15 | 24 | 18 | 17 | 25 | 15 | 24 | 18 | 25 | 15 | 24 | 18 | 17 | |
| 0 | 10 | 4 | 6 | 7 | 11 | 14 | 20 | 32 | 0 | 2 | 11 | 12 | 22 | 31 | 31 | 0 | 4 | 10 | 7 | 0 | 11 | 22 | 28 | 31 | |
| 17 | 18 | 24 | 15 | 0 | 17 | 18 | 15 | 24 | 25 | 17 | 15 | 25 | 18 | 24 | 17 | 25 | 15 | 18 | 24 | 25 | 24 | 15 | 18 | 17 | |
| 17 | 18 | 15 | - | - | 17 | 15 | - | - | - | 18 | 17 | 15 | 24 | - | 17 | 18 | 15 | 24 | - | 18 | 24 | 15 | 17 | 20 | |
| 10 | 11 | 7 | 9 | 22 | 11 | 14 | 9 | 32 | 17 | 10 | 11 | 32 | 8 | 9 | 10 | 11 | 24 | 23 | 32 | 10 | 11 | 14 | 23 | 9 | |
| 17 | 18 | 24 | 15 | 3 | 17 | 18 | 15 | 24 | 25 | 17 | 15 | 25 | 18 | 24 | 17 | 25 | 15 | 24 | 18 | 25 | 15 | 24 | 18 | 17 | |
| 17 | 18 | 15 | 24 | 33 | 17 | 18 | 15 | 20 | 25 | 17 | 18 | 29 | 15 | 25 | 17 | 25 | 18 | 23 | 15 | 18 | 17 | 25 | 15 | 23 | |
Clusters were evaluated in every time point with several topological metrics as defined in Hubba analyzer. Also, the indegree, outdegree and betweenness centrality scores were calculated with the use of Cytoscape plugins. We display the top 5 clusters (with descending rank order) at every time point with the highest scores in every metric, with the exception of BN metric where only few clusters had score > 0.
KEGG Pathway analysis
| Outdegree/Betweenness Centrality | |||
|---|---|---|---|
| 3 | no pathway | ||
| 15 | B cell receptor signaling pathway | 11.5 | 8.00E-03 |
| 17 | RIG-I-like receptor signaling pathway | 21.1 | 6.30E-06 |
| Cytosolic DNA-sensing pathway | 15.8 | 5.30E-04 | |
| Toll-like receptor signaling pathway | 10.5 | 6.70E-02 | |
| 18 | Natural killer cell mediated cytotoxicity | 16.7 | 2.60E-03 |
| Graft-versus-host disease | 11.1 | 4.00E-02 | |
| Allograft rejection | 11.1 | 4.00E-02 | |
| 20 | drug metabolism | 10.8 | 1.30E-03 |
| 23 | Jak-STAT signaling pathway | 6.0 | 9.60E-03 |
| Lysosome | 4.8 | 2.80E-02 | |
| Cell adhesion molecules (CAMs) | 4.8 | 5.30E-02 | |
| 24 | Cytokine-cytokine receptor interaction | 22.7 | 4.50E-05 |
| Chemokine signaling pathway | 18.2 | 5.90E-04 | |
| NOD-like receptor signaling pathway | 13.6 | 1.70E-03 | |
| Cytosolic DNA-sensing pathway | 9.1 | 5.60E-02 | |
| Hematopoietic cell lineage | 9.1 | 8.50E-02 | |
| Toll-like receptor signaling pathway | 9.1 | 9.90E-02 | |
| 29 | Proteasome | 6.3 | 1.00E-03 |
| Apoptosis | 4.8 | 5.40E-02 | |
| Toll-like receptor signaling pathway | 4.8 | 6.80E-02 | |
| 33 | Aldosterone-regulated sodium reabsorption | 3.4 | 7.40E-03 |
| 7 | DNA replication | 9.7 | 4.60E-09 |
| Mismatch repair | 5.6 | 9.40E-05 | |
| 8 | Apoptosis | 3.2 | 1.40E-02 |
| p53 signaling pathway | 2.4 | 6.00E-02 | |
| 9 | Chemokine signaling pathway | 8.9 | 8.80E-03 |
| Jak-STAT signaling pathway | 6.7 | 5.20E-02 | |
| 10 | Antigen processing and presentation | 8.7 | 2.40E-05 |
| Allograft rejection | 7.2 | 7.20E-04 | |
| Endocytosis | 8.7 | 1.00E-03 | |
| Viral myocarditis | 5.8 | 5.90E-03 | |
| 11 | Complement and coagulation cascades | 8.2 | 3.10E-05 |
| Cytokine-cytokine receptor interaction | 9.6 | 1.70E-03 | |
| 14 | Natural killer cell mediated cytotoxicity | 13.5 | 5.00E-08 |
| T cell receptor signaling pathway | 8.5 | 8.70E-04 | |
| Primary immunodeficiency | 5.4 | 5.70E-03 | |
| Cell adhesion molecules (CAMs) | 8.1 | 2.80E-03 | |
| Leukocyte transendothelial migration | 6.8 | 6.80E-03 | |
| Cytokine-cytokine receptor interaction | 8.1 | 1.90E-02 | |
| Cell adhesion molecules (CAMs) | 3.8 | 1.70E-02 | |
| Cytokine-cytokine receptor interaction | 8.1 | 1.90E-02 | |
| Cell adhesion molecules (CAMs) | 3.8 | 1.70E-02 | |
| 22 | DNA replication | 3.4 | 2.30E-03 |
| Cytokine-cytokine receptor interaction | 5.2 | 3.80E-02 | |
| 23 | Jak-STAT signaling pathway | 6.0 | 9.60E-03 |
| Cell adhesion molecules (CAMs) | 4.8 | 5.80E-02 | |
| 24 | Cytokine-cytokine receptor interaction | 22.7 | 5.40E-05 |
| Chemokine signaling pathway | 18.2 | 5.90E-04 | |
| NOD-like receptor signaling pathway | 13.6 | 1.70E-03 | |
| 32 | Cytokine-cytokine receptor interaction | 19.6 | 2.00E-09 |
| NOD-like receptor signaling pathway | 8.9 | 5.30E-05 | |
| Toll-like receptor signaling pathway | 8.9 | 1.30E-04 | |
All top scorer clusters, with regard to indegree, outdegree and betweenness centrality metrics, were checked for enriched KEGG pathways.
Figure 2Degree Distribution. Indegree and outdegree distribution averaged over 5 time points. The x-axis represents the indegree/outdegree score, while the y-axis depicts the total number of clusters.
Figure 3Network Graph Structures. Network graph structures of the resulting TV-DBNs. Two indicative networks with different sized nodes from time point 3 are displayed, in terms of (a) outdegree score and (b) indegree score. Each node represents the time (t) of the respective network and the corresponding cluster number.
Figure 4Network Size/Local Clustering Coefficient. Plot of two network statistics (network size, clustering coefficient) as functions of time line. It is obvious that network size evolves in a very different way from the local clustering coefficient.
Figure 5Size of recovered interactions. This histogram shows the size of known PPI and protein-DNA interactions recovered per time point. It is apparent that there is an increase in the traced interactions the first 4 days p.i.
Timeline of PPI/Protein-DNA interactions
| A | B | C | D | E | PPI/Protein-DNA interaction | |
|---|---|---|---|---|---|---|
| ● | ● | Relb | Cxcl13 | |||
| ● | ● | ● | ● | ● | Nfkb2 | Cxcl13 |
| ● | ● | ● | ● | ● | Nfkbiz | Il6 |
| ● | ● | ● | Bcl3 | Cyld | ||
| ● | ● | ● | ● | ● | Stat1 | Gm9706 |
| ● | ● | ● | Prkcz | Junb | ||
| ● | ● | ● | ● | ● | Cxcl10 | Cxcr3 |
| ● | ● | ● | ● | ● | Stat1 | Cxcl10 |
| ● | ● | ● | ● | ● | Stat2 | Cxcl10 |
| ● | ● | ● | ● | ● | Irf9 | Cxcl10 |
| ● | ● | Plcg2 | Spnb2 | |||
| ● | ● | ● | Tlr2 | Tlr6 | ||
| ● | Ncor1 | Cxcl10 | ||||
| ● | ● | ● | ● | Stat4 | Ifng | |
| ● | ● | ● | ● | Tbx21 | Ifng | |
| ● | ● | ● | ● | Bid | Gzmb | |
| ● | ● | ● | ● | ● | Irf1 | Gbp2 |
| ● | ● | Irf1 | Il27 | |||
| ● | ● | ● | ● | Gpnmb | Pla2g4a | |
| ● | ● | Sfpi1 | Il1b | |||
| ● | ● | Tbp | Ifng | |||
| ● | ● | ● | ● | ● | Ccl7 | Ccr2 |
| ● | ● | Sfpi1 | Cxcl9 | |||
| ● | Cxcl9 | Cxcr3 | ||||
| ● | ● | ● | ● | Stat1 | Cxcl9 | |
| ● | ● | ● | ● | ● | Lcp2 | Vav1 |
| ● | ● | ● | ● | ● | Ptpn6 | Vav1 |
| ● | ● | ● | ● | Ccl4 | Ccr5 | |
| ● | ● | Ncor1 | Ccl4 | |||
| ● | ● | Irf1 | Il15 | |||
| ● | ● | ● | ● | ● | Gzmb | Serpinb9 |
| ● | ● | ● | ● | Dok2 | Tek | |
| ● | ● | ● | Rad21 | Ifng | ||
| ● | ● | Ccl2 | Ccrl2 | |||
| ● | ● | ● | ● | ● | Etv6 | Lcn2 |
| ● | ● | ● | ● | Ripk | Zbp1 | |
| ● | ● | ● | ● | ● | Irf7 | Myd88 |
| ● | ● | ● | ● | ● | Irf7 | Ifnb1 |
| ● | ● | ● | ● | ● | Stat1 | Irf7 |
| ● | ● | ● | ● | Gadd45g | Loc100046823 | |
| ● | ● | ● | ● | Irf8 | Cxcl9 | |
| ● | ● | ● | ● | Irf8 | Gm9706 | |
| ● | ● | ● | ● | ● | Ccl2 | Ccr2 |
| ● | ● | Junb | Il6 | |||
| ● | ● | ● | ● | Atf3 | Il6 | |
| ● | ● | Runx3 | Ifng | |||
| ● | ● | Ncor1 | Ccl2 | |||
| ● | Gzmb | Hopx | ||||
| ● | ● | ● | ● | Irf7 | Ifna4 | |
| ● | ● | ● | ● | Ncor1 | Cxcl9 | |
| ● | ● | ● | ● | Il1rl1 | Myd88 | |
Each line in the table corresponds to one PPI or protein-DNA interaction. The bullets indicate the exact day (A: day 1 p.i., B: day 2 p.i., C: day 3 p.i., D: day 4 p.i., E: day 5 p.i.) that the corresponding interaction is present in the resulting network.